Immunomodulation of chiclero's ulcer. Role of eosinophils, T cells, tumour necrosis factor and interleukin-2

Scandinavian Journal of Immunology

Volumn 47, Issue 5, 1998, Pages 502-508

  Lezama Davila C M ^a,e   Isaac Marquez A P ^b   Padierna Olivos, J ^d   Aguilar Torrentera, F ^c   Chapa Ruiz, R ^c  

^a UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE CAMPECHE   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^d Laboratorio de Especialidades Inmunologicas   (Mexico)

^e NONE   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2; TUMOR NECROSIS FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; EOSINOPHIL; EOSINOPHILIA; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOLOGY; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SKIN LEISHMANIASIS; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CYTOKINES; EOSINOPHILS; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-2; LEISHMANIASIS, CUTANEOUS; LEUKOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031746919     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00328.x     Document Type: Article

References (48)

1. Modabber F. The leishmaniasis. Eighth program report of the UNDP/World Bank/WHO. In: Maurice J, Pearce AM, eds. Tropical Disease Research: A Global Partnership. Geneva: World Health Organization, 1987:99-112.
2. Lezama-Dávila CM, Isaac-Márquez AP. Inmunobiología de Las Leishmaniasis. México: UAC-FOMES, 1995.
3. Lezama-Dávila CM. Immunoregulation of Cutaneous Leishmaniasis by Vaccination and Immunotherapy. PhD thesis, Glasgow, UK, 1991.
4. Scott P. The role of Th1 and Th2 cells in experimental cutaneous leishmaniasis. Exp Parasitol 1989;68:369.
5. Scott P, Farrell JP. In vivo alterations in cytokine production following interleukin-12 (IL-12) and anti-IL-4 antibody treatment of CB6F1 mice with chronic cutaneous leishmaniasis. Infect Immun 1996;64:5248.
6. Scott P, Natovitz P, Cooffman RL, Pearce E, Sher A. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J Exp Med 1988;168:1675.
7. Liew FY. Role of T cells in the unusual cutaneous response to Leishmania in the BALB/c mice. Curr Top Microbiol Immunol 1985;122:122.
8. Mc Elrath MJ, Murray HW, Nusrat A, Cohn Z. A Cutaneous leishmaniasis. The defect in T cell influx in BALB/c mice. J Exp Med 1987;165:546.
9. + T cells in leishmaniasis. Immunol Today 1989;10:40.
10. + T cells in susceptible BALB/c as compared to resistant CBA/c. mice. J Immunol 1986; 136:1467.
11. + T cell subsets in murine leishmaniasis. In: McAdam KPWJ ed. Frontiers in Infectious Diseases, New Strategies in Parasitology. Hertfordshire: Churchill Livingstone 1989:147-57.
12. + cytotoxic T cells and Leishmania-infected macrophages. J Exp Med 1991;174:499.
13. + T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis. Eur J Immunol 1987;17:1429.
14. + T cells in resistance to cutaneous leishmaniasis in immunized mice. J Immunol 1989; 142:2052.
15. + T lymphocytes in intracellular microbial infections. Immunol Today 1988;9:168.
16. + T lymphocytes to mediate protective immunity against Leishmania. J Exp Med 1989;169:1819.
17. - T cell-subsets can confer protection against Leishmania m. mexicana infection. Mem Inst Osw Cruz 1995;90:51.
18. Mossmann TR, Coffman RL. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 1989;46:111.
19. Romagnani S. Human Th1 and Th2 subsets: Doubt no more. Immunol Today 1993;12:256.
20. + T lymphocytes. Sci Am Sci Med 1994;1:68.
21. Locksley R.M. Th2 cells: Help for helminths. J Exp Med 1994;179:1405.
22. Romagnani S. Lymphokine production by human T cells in disease states. Ann Rev Immunol 1994;12:227.
23. Sher A, Coffman RL. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Ann Rev Immunol 1992;10:385.
24. Müller I, Pedrazzini T, Farrell JP, Louis J. T cell responses and immunity to experimental infection. Ann Rev Immunol 1989;7:561.
25. Lezama-Dávila CM, Williams D, Gallagher G, Alexander J. Cytokine control of Leishmania infection in the BALB/c mouse: enhancement and inhibition of parasite growth by local administration of IL-2 or IL-4 is species and time dependent. Parasite Immunol 1992;14:37.
26. Carter C, Gallagher G, Baillie A, Alexander J. The induction of protective immunity to L. major in the BALB/c mouse by treatment with IL-4. Eur J Immunol 1989;19:779.
27. Kemp M, Kurtzhals JAL, Bendtzen K et al. L. donovani-reactive Th1 and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis. Infect Immun 1993;61:1069.
28. Melby PC, Andrade-Narvaez F, J-Darnell B, Valencia-Pacheco G, Tryon VV, Palomo-Cetina A. Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis. Infect Immun 1994;62:837.
29. Wershil BK, Theodos CM, Galli SJ, Titus RG. Mast cells augment lesion size and persistance during L. major infection in the mouse. J Immunol 1994;152:4563.
30. Ngo TT, Lenhoff HM. New approach to heterogeneous enzyme-immunoassays using tagged enzyme-ligand conjugates. Biochem Biophys Res Commun 1981;99:496.
31. Mason DW, Penhale WJ, Sedwick JD. Preparation of lymphocyte subpopulations. In: Klaus GGB, ed. Lymphocytes, A Practical Approach. Oxford: IRL Press, 1987:35-54.
32. Lezama-Dávila CM, Gallagher G. Vaccination of C57BL/6 mice against cutaneous leishmaniasis. Kinetics of antibody synthesis and induction of cellular responses. In Vivo 1995;9:519.
33. Lezama-Dávila CM. Vaccination of different strains of mice against cutaneous leishmaniasis. Usefulness of membrane antigens encapsulated into liposomes by intraperitoneal and subcutaneous administration. Arch Med Res 1997;28:43.
34. Machado-Coelho GLL, Caiaffa WT. Immunotherapy for american cutaneous leishmaniasis (ACL): Evaluation of length of treatment. Mem Inst Osw Cruz 1996;91(Suppl.): 204.
35. Sousa CSF, Oliveira-Neto MP, Lagrange PH, Goncalves Da Costa SC. Immunomodulation of adenenopathies in American cutaneous leishmaniasis. Mem Inst Osw Cruz 1996;91(Suppl.):177.
36. Aggarwal BB, Natarajan K. Tumor necrosis factors: Development during the last decade. Eur Cytokine Netw 1996;7:93.
37. Boise LH, Thomson CB. Hierarchical control of lymphocyte survival. Science 1996;272:67.
38. Coffman R, von der Weid T. Multiple pathways for the initiation of T helper 2 (Th2) responses. J Exp Med 1997;185:373.
39. Freeman GL Jr., Montesano MA, Secor WE, Colley DG, Howard MJ, Bosshardt SC. Immunopathogenesis and immunoregulation in shistosomiasis. Ann New York Acad Sci 1996;797:151.
40. Wheatley LM, Platts-Mills TAE. Perennial antigens and asthma epidemic. Sci Am Sci Med 1996;3:6.
41. Moss GB, Hamilos DL, Korenblat PE. Denning threshold steroid dose and correlation with absolute eosinophil counts in steroid-dependent asthmatics. J Allergy Clin Immunol 1997;99:S320.
42. Cohen AJ, Steigbigel RT. Eosinophilia in patients infected with human immunodeficiency virus. J Infect Dis 1997;174:615.
43. Lezama-Dávila CM, Isaac-Márquez AP, Romero-Leonardo JJ, Padiema-Olivos J, Aguilar-Torrentera F. Serum levels of TNF and related cytokines in relation to lymphocyte proliferation in humans with chiclero's ulcer. Eur Cytokine Netw 1996;7:263.
44. Barral A, Freitas V, Barbosa T. Apoptosis in peripherial blood or bone marrow lymphocytes from visceral leishmaniasis patients. Mem Inst Osw Cruz 1996;91(Suppl.):169.
45. Da Cruz AM, Pereira de Oliveira M, Mello De Luca P, Mendonca SCF, Coutinho SG. Tumor necrosis factor-α in human American tegumentary leishmaniasis. Mem Inst Osw Cruz 1996;91:225.
46. Uyemura K, Klotz J, Pirmez C et al. Microanatomic clonality of γδ T cells in human leishmaniasis lesions. J Immunol 1992;148:1205.
47. Broodskin CI, Barrai A, Bonaventure V, Carvalho EM. Parasite-driven lymphocyte cytotoxicity against autologous infected macrophages in mucosal leishmaniasis patients. Mem Inst Osw Cruz 1996;91(Suppl.):170.
48. Modlin RL, Pirmez C, Hoffman FM et al. Lymphocytes bearing antigen-specific 76 T cell receptors accumulate in human infectious disease lesions. Nature 1989;339:544.